🇺🇸 FDA
Patent

US 7439399

Processes for the preparation of atomoxetine hydrochloride

granted A61PA61P25/00

Quick answer

US patent 7439399 (Processes for the preparation of atomoxetine hydrochloride) held by Teva Pharmaceutical Fine Chemicals S.R.L. expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Teva Pharmaceutical Fine Chemicals S.R.L.
Grant date
Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P25/00